This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ITS USE IN TWENTY-SIX CASES OF EARLY SYPHILIS

LEE J. ALEXANDER, M.D.; ARTHUR G. SCHOCH, M.D.

Arch Derm Syphilol. 1942;45(5):876-884.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The therapeutic value of a drug used in the treatment of syphilis is dependent on certain well known factors, of which the most important are (1) the spirocheticidal effectiveness of the preparation, on which in turn depends the rapidity of the healing of the lesions, (2) the serologic response of the patient and (3) the tolerance of the patient for the drug from the standpoint of immediate and delayed local and systemic reactions. These properties can best be determined in cases of early syphilis (primary and secondary) and in animal syphilis.

Previous studies have been made on the therapeutic effectiveness of bismuth ethyl camphorate. Thurmon¹ found this preparation, which is a liposoluble bismuth salt of ethyl camphoric acid, having 23.47 per cent bismuth (40 mg. elemental bismuth per cubic centimeter), to be an extremely valuable adjunct to the arsphenamines in the treatment of syphilis. In a later study, Thurmon . . . [Full Text PDF of this Article]

Author Affiliations
DALLAS, TEXAS

From the Dallas Syphilis and Venereal Disease Clinic, Department of Health, Parkland Hospital.

Footnotes
This study was made possible by a grant from The Upjohn Company, Kalamazoo, Mich.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?